Bellmunt, J., Rodriguez-Vida, A., Martinez, I., Mendez-Vidal, M. J., Gonzalez, C., Álvarez-Fernández, C., González, N. S., Buisan, O., Pallares, M. J. M., Gajate, P., Fernández, O., Sorrosal, J. J. L., Sánchez, J. G., Castellano, D., Sevillano, E., Lázaro, M., Mazon, F. J. V., Maroto-Rey, P., Gallardo, E., Faba, O. R. (2025). A phase II prospective, open-label, multi-center, single-arm study of sasanlimab plus sacituzumab govitecan in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) pts: SSANTROP (APRO07-2022).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4596